Dave S. Sprengers - Publications

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 19, 2026

Perspectives on TLR2 agonist use in the road map to HBV cure.

Journal: Antiviral research

Published: March 16, 2026

Selective internal radiotherapy vs transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic review.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association

Published: November 17, 2025

Clinical Utility and Diagnostic Accuracy of the GAAD Score in Non-cirrhotic Patients With Focal Liver Lesions.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 15, 2025

Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort.

Journal: JHEP reports : innovation in hepatology

Published: June 16, 2025

Increasing incidence and changing trends in etiology & survival rates in HCC in a European cohort.

Journal: JHEP reports : innovation in hepatology

Published: June 16, 2025

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Journal: Alimentary pharmacology & therapeutics

Published: May 23, 2025

Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 24, 2025

Hepatobiliary scintigraphy and liver function changes in patients with hepatocellular carcinoma treated with 166Ho-radioembolization : HBS in HCC treated with holmium-166.

Journal: EJNMMI research

Published: October 14, 2024

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: September 29, 2024

Holmium-166 radioembolisation dosimetry in HCC.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 07, 2024

Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma.

Journal: Clinical and translational radiation oncology

Published: June 08, 2024